Cargando…
Convalescent plasma for the treatment of patients with severe coronavirus disease 2019: A preliminary report
BACKGROUND: The role of convalescent plasma therapy for patients with coronavirus disease 2019 (COVID‐19) is unclear. METHODS: We retrospectively compared outcomes in a cohort of critical COVID‐19 patients who received standard care (SC Group) and those who, in addition, received convalescent plasma...
Autores principales: | Omrani, Ali S., Zaqout, Ahmed, Baiou, Anas, Daghfal, Joanne, Elkum, Naser, Alattar, Rand A., Bakdach, Dana, Abusriwil, Hatem, Mostafa, Abdalrahman M., Alhariri, Bassem, Ambra, Naseem, Khatib, Mohamed, Eldeeb, Ali M., Merenkov, Zeyd, Fawzi, Zeinab, Hmissi, Saloua M., Hssain, Ali A., Coyle, Peter V., Alsoub, Hussam, Almaslamani, Muna A., Alkhal, Abdullatif |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7537323/ https://www.ncbi.nlm.nih.gov/pubmed/32965715 http://dx.doi.org/10.1002/jmv.26537 |
Ejemplares similares
-
Clinical characteristics and risk factors for the isolation of multi-drug-resistant Gram-negative bacteria from critically ill patients with COVID-19
por: Baiou, A., et al.
Publicado: (2021) -
The first consecutive 5000 patients with Coronavirus Disease 2019 from Qatar; a nation-wide cohort study
por: Omrani, Ali S., et al.
Publicado: (2020) -
Acinetobacter Infections among Adult Patients in Qatar: A 2-Year Hospital-Based Study
por: Al Samawi, Musaed Saad, et al.
Publicado: (2016) -
Favipiravir for the treatment of coronavirus disease 2019 pneumonia; a propensity score-matched cohort study
por: Alattar, Rand A., et al.
Publicado: (2022) -
163. Infective Endocarditis in Qatar: Risk Factors, Clinical Characteristics, Microbiology, and Outcomes
por: Zaqout, Ahmed, et al.
Publicado: (2019)